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Key points 
• In total, 206 patients with autism were screened for rearrangements involving the Williams-Beuren 
Critical Region (WBCR) in 7q11.23. 
• The case of a patient with autism, language delay and mental retardation who has a de novo 
duplication of the WBCR from paternal origin is reported. 
• The clinical picture resulting from the WBCR duplication is discussed.  
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ABSTRACT 
Background: Chromosomal rearrangements, arising from unequal recombination between repeated 
sequences, are found in a subset of patients with autism. Duplications involving loci associated with 
behavioural disturbances especially constitute a good candidate mechanism. The Williams-Beuren 
Critical Region (WBCR), located in 7q11.23, is commonly deleted in the Williams-Beuren 
microdeletion syndrome (WBS). However, only four patients with a duplication of the WBCR have 
been reported so far, one with severe language delay and the three others with variable developmental, 
psychomotor and language delay.  
Objective and Methods: In this study, we screened 206 patients with autism spectrum disorders for 
the WBCR duplication by quantitative microsatellite analysis and multiple ligation-dependent probe 
amplification (MLPA). 
Results: We have identified one male patient with a de novo interstitial duplication of the entire 
WBCR of paternal origin. The patient had autistic disorder, severe language delay and mental 
retardation, with very mild  dysmorphic features. 
Conclusion: We report the first patient with autistic disorder who has a WBCR duplication. This 
observation indicates that the 7q11.23 duplication could be involved in complex clinical phenotypes, 
ranging from developmental or language delay to mental retardation and autism, and extends the 
phenotype initially reported. These findings also support the existence of one or several genes in 
7q11.23 sensitive to gene dosage and involved in the development of language and social interaction. 
 
 
Chromosomal micro-rearrangements have been increasingly identified as a cause of human 
developmental disorders. Most often, they are the consequence of recombination between highly 
homologous (>95%) sequences called duplicons (spanning >10 kb) that flank a relatively small region 
(usually <5 Mb), leading to deletion or duplication of the region.1-3 Deletions and duplications alter the 
normal dosage of several adjacent genes and are responsible for contiguous gene syndromes or single 
gene disorders. One of these disorders, the Williams-Beuren syndrome (WBS), is caused by a 
microdeletion in the pericentromeric 7q11.23 region. This genomic disorder (1 in 7500 births)4 is 
characterized by typical dysmorphic features, mental retardation, developmental and language delay, 
congenital heart disease and hypersensitivity to sounds. Individuals with WBS also exhibit 
hypersociability and a characteristic neurocognitive profile, with poor visuospatial skills but relatively 
preserved ability to communicate.5 Although WBS has sometimes been described as the opposite of 
autism, recent studies indicate that they share many features, including pragmatic language 
impairments, poor social relationships and unusual or restricted interests.6 Furthermore, the 
hypersensitivity to sound often described in patients with WBS7 is reminiscent of the heightened 
response to auditory stimuli observed in autism.8 Even though autism had been described in 
association with WBS only in a small number of patients,9-11 a recent study of 128 4-to-16 year old 
patients with WBS identified nine children with autism spectrum disorders,12 indicating that the 
coexistence of the two disorders is not coincidental. 
Autism is a complex developmental disorder, characterized by impairment in social interactions 
and communication and repetitive interests and behaviours. It generally occurs sporadically, but in 
~5% of the cases, multiple affected subjects are found in families. Twin and family studies have 
shown that autism has a strong heritable component; the genetic mechanisms are likely to be complex 
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and heterogeneous, as suggested by the imbalanced sex ratio (4 males to 1 female) and its frequent 
association with known genetic diseases (e.g., fragile X, tuberous sclerosis, neurofibromatosis)13 or 
chromosomal rearrangements (e.g., 15q11-q13 duplication, 22q13.3 deletion). 14,15  
Although unequal crossing over between duplicons is expected to lead to reciprocal deletions and 
duplications of the Williams-Beuren Critical Region (WBCR) with a similar frequency, the first case 
of a duplication of the WBCR was described only in 2005, in a patient with severe language delay.16 
More recently, three additional patients were reported: one had trigonocephalic synostosis, mild 
developmental delay and moderate language disability17; a second had severe learning and speech 
disabilities, mild dysmophism, moderate mental retardation and poor social skills18 and a third had 
severe speech impairment associated with epilepsy and cortical dysplasia of the left temporal lobe.19 
No clear phenotype has been attributed to the WBCR duplication, making clinically-oriented 
screening by FISH impractical. In the current study, we screened 206 patients with autism spectrum 
disorders from the PARIS (Paris Autism Research International Sibpair) study cohort for deletion/ 
duplication of the 7q11.23 region by quantitative microsatellite analysis and multiple ligation-
dependent probe amplification (MLPA). We report the identification of a new patient with a de novo 
duplication of the WBCR, who had autism, severe language impairment, and mental retardation. 
 
 
MATERIALS AND METHODS 
Patients 
A total of 206 patients with an autism spectrum disorder were studied. They were recruited at 
specialized clinical centres in France as part of the PARIS study. The patients included 160 males and 
46 females; 156 were sporadic cases and 50 subjects belonged to 27 families with two or more 
affected siblings. Diagnoses were based on clinical evaluation by experienced psychiatrists, DSM-IV 
criteria20 and the Autism Diagnostic Interview-Revised (ADI-R).21 There were 199 patients with 
autism, 4 with pervasive developmental disorder-not otherwise specified and 3 with Asperger 
syndrome. Among the patients studied, 182 had mental retardation and 114 had very limited or no 
language. Most were Caucasian (n=172), 13 Black, 3 South Asian and 18 of mixed ethnicity. 
Laboratory tests included karyotyping, fragile X testing and metabolic screening; brain imaging and 
EEG were performed when possible. Patients with known genetic disorders were excluded. The local 
research ethics board approved the study. Informed consent was obtained from all participating 
families. 
 
Quantitative microsatellite analysis 
Two microsatellite markers (D7S809 and D7S3315) were used to perform quantitative allele dosage at 
the 7q11 locus (Figure 1). D7S3315 was developed using the Tandem Repeat Finder algorithm 
(http://tandem.bu.edu/trf/trf.html) and registered in the GDB Human Genome Database. Nine other 
microsatellite markers located inside (AFMA217XH1, D7S2479, D7S2476, D7S613, and D7S1870) 
or outside (D7S645, D7S672, D7S2490, and D7S2518) the WBCR were used to analyze the 
haplotypes transmitted at the 7q11.23 locus. Primers and experimental conditions used are indicated in 
supplementary table S1, available online. Amplification was performed in 25 µl containing 0.5 U 
AmpliTaq DNA Polymerase (Applied Biosystems, Foster City, California, USA), 2.5 µl 10X buffer 
(containing 15 mM MgCl2), 0.1 µl dNTP (25 µmol/l), 0.4 µl of 6-FAM fluorochrome 5’-labeled 
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forward primer (20 µmol/l), 0.4 µl of reverse primer and 100 ng of genomic DNA. PCR reactions 
were carried out in a thermocycler (Primus 96 Plus; MWG-Biotech, Highpoint, North Carolina, USA). 
PCR products were separated and quantified on an automated sequencer (ABI 3730; Applied 
Biosystems). 
 
Multiplex ligation-dependent probe amplification (MLPA) 
A commercial kit (Williams-Beuren Syndrome MLPA kit, P029, designed to search for 7q11.23/ELN 
deletions or duplications), was used according to the manufacturer’s instructions (MRC-Holland, 
Amsterdam, The Netherlands). Two other MLPA kits (the mental retardation P019/P020 kit for 
subtelomeric regions and P064, MR1) were used to exclude the presence of rearrangements in other 
candidate regions. Electrophoresis of PCR products was performed using an automated sequencer 
(ABI 3730; Applied Biosystems). Samples were run in triplicate. MLPA data were analysed using the 
GeneMapper 4.0 software (Applied Biosystems). Relative ratios were calculated for each peak using 
the formula r = mean (peak area patient/mean control area patient)/(peak area control individual/mean control area 
control individual). 
 
Real-time quantitative PCR 
Real-time quantitative PCR has been previously used to assess the copy number in the 7q11.23 
region.22,23 To determine the allele copy numbers at the boundaries of the WBCR, we designed four 
primer pairs using Primer Express 1.5 software (Applied Biosystems). Two primer pairs were located 
inside the WBCR (in the FKBP6 and GTF2I genes), the other two flanked the region (next to the 
AFMA217XH1 marker and in the HIP1 gene, fig 1). Primer sequences are indicated in E-Table S2. 
Real-time amplifications were performed using 50 ng of genomic DNA, 0.4 µM of each primer and 
12.5 µl of Sybr Green PCR master mix (Applied Biosystems) in a total volume of 25 µl. RNAse P 
(RNAse P control assay, Applied Biosystems) was used as the reference amplimer. Samples were run 
in triplicate on an automated dDetection system (ABI Prism 7700; Applied Biosystems) using 
standard conditions: 2 min at 50°C; 10 min at 95°C; 40 cycles of 15 s at 95°C, and a final step of 1 
min at 60°C. Relative ratios were calculated using the formula r = mean 2–∆∆Ct, where 
∆∆Ct = (Ct Mutation - Ct RNAseP) ind tested – (Ct Mutation – Ct RNAseP) ind ref. 
 
Fluorescence in situ hybridization 
Metaphase chromosome spreads and interphase nuclei preparations were obtained from 
lymphoblastoid cell lines from the patient using standard high resolution-banding methods. A specific 
DNA probe (D7S2476-D7S1465) for the WBCR, covering the ELN, LIMK1 and CYLN2 genes, was 
obtained from Q-BIOgene (MP Biomedicals, Illkirch, France). The specific probe was labelled with 
rhodamine and the 7q22 control probe  with fluorescein isothiocyanate (FITC). FISH was carried out 
according to the supplier's protocol. Briefly, the slides were washed in 2 x SSC/0.5% NP40 at 37°C 
for 30 min, dehydrated in 70%, 80% and 95% ethanol at room temperature for 2 min each, co-
denatured with the probe at 75°C for 5 min and incubated overnight at 37°C in a humidified chamber 
for hybridization. The slides were then washed and counterstained with 4,6-diamino-2-phenylindole 
(DAPI) for chromosome identification. Metaphase and interphase cells were examined under a 
motorized reflected fluorescence microscope (BX61; Olympus, Center valley, Pennsylvania, USA) 
with filters for separate detection of DAPI, FITC and rhodamine, as well as a triple bandpass filter to 
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detect signals simultaneously. In total, 50 metaphase and 50 interphase cells were examined to detect 
cells with >2 specific signals. 
 
 
RESULTS 
Screening and characterization of 7q11 duplication 
In total, 206 patients with autistic spectrum disorder were screened for 7q11 rearrangements using 
quantitative microsatellite analysis with the D7S809 and D7S3315 markers and MLPA (Fig 1A). In 
the presence of a duplication, quantitative microsatellite analysis can detect either more than two peaks 
(when the alleles are all different) or an imbalance between the peaks (when two alleles are identical 
and the third is different).24 One proband had three different alleles for each marker, which suggested 
that the region could be duplicated (Fig 1B). The duplication was confirmed by the presence of three 
alleles for D7S613 and D7S2476 as well. Two additional markers located inside the minimal region 
near the boundaries (D7S2479 and D7S1870) were uninformative. Four markers located outside the 
WBCR, either on the proximal (D7S672 and D7S645) or distal (D7S2490 and D7S2518) part, were 
found to be normal (Fig 1C). Analysis of the parents showed that the duplication was de novo and of 
paternal origin, since the child had the two alleles from his father (Fig 1B and C). MLPA analysis of 
the 7q11 region confirmed that the FKBP6, FZD9, TBL2, STX1A, ELN, LIMK1, RFC2 and CYLN2 
genes, all comprised within the WBCR, were duplicated (Fig 1D). To further delimit the duplicated 
region, we developed four real-time PCR assays (Q-PCR-1 to 4) to quantify allele copy number near 
the boundaries of the region. These assays confirmed the presence of three alleles (1.5 ratio compared 
to the control) for the FKBP6 and GTF2I genes and only two copies for the two assays with probes 
flanking the WBCR region, in the 7q11.22 distal region and in the HIP1 gene, respectively (Fig 1E). 
Finally, the interstitial 7q11 duplication in the proband was confirmed by FISH. Interphase nuclei 
showed three specific 7q11-probe signals (Fig 2A). FISH analysis of metaphase chromosomes 
revealed two hybridization spots, one brighter than the other (Fig 2B), confirming that the third copy 
was in 7q11. Taken together, these results demonstrate that the chromosomal rearrangement detected 
in the proband is a tandem 7q11.23 duplication that corresponds exactly to the WBCR. 
The co-occurrence of clinical features and de novo 7q11.23 duplication strongly argues in favour 
of a causative role of the rearrangement detected in the patient’s phenotype. However, we additionally 
screened 300 control individuals for WBCR duplication by quantitative microsatellite analysis to 
ensure that this duplication was not present in a control population. No rearrangement was identified, 
indicating that the 7q11.23 duplication is either pathological or very rare in healthy individuals. 
Finally, additional genetic analyses in the patient using MLPA and/or quantitative PCR excluded 
chromosomal abnormalities involving the 15q11.2, 22q11.2, 17p11.2, 22q13, 1p36, 17p13.3, 20p12.2, 
5q35.3 as well as all telomeric regions. Karyotype, fragile X testing, plasma and urine amino acids 
were normal. 
 
Clinical features of the patient with the 7q11 duplication 
The proband was the second child of non-consanguineous parents. His father and sister were healthy; 
his mother possibly had obsessive-compulsive disorder. Pregnancy was unremarkable. He was born at 
term by caesarean section for umbilical cord strangulation, but the Apgar score was normal. His birth 
weight was 2870 g (-1.2 SD) and his length 50 cm (50th percentile). He was a hypotonic baby and 
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made no eye contact. His early development was delayed; he sat at 15 months and walked at 26 
months. He also had markedly delayed language and pronounced his first words at 3 years. An 
auditory evaluation performed at 18 months was normal. He was diagnosed as having autistic disorder 
and mental retardation at 30 months according to DSM-III criteria. He attained bladder and bowel 
continence at night at 4 years and partially during the day at 11 years. At 9 years, he was able to bathe, 
dress and feed himself. Interestingly, he showed hypersensitivity to noise. He had stereotypic 
behaviour, with numerous routines and difficulty tolerating changes in daily habits. He was markedly 
hyperactive and exhibited inappropriate behaviour towards strangers, rushing up to people to hug them 
or hit them. He showed a particular interest in food that he hid in his room. He also had hyperphagia. 
Furthermore, he showed numerous stereotypies: head nodding, repetitive jaw movements, and 
mannerisms of the hands and arms. He was unable to express interest.  
When last examined at the age of 12 years 5 months, he was still incontinent during the day. He 
had aggressive behaviour with severe outbursts of anger in response to frustration. He also had 
paroxystic episodes triggered by intense laughter and lasting ~3 min, when he stared into space and 
became pale, falling down without hurting himself, occurring about three times per month. His head 
circumference was 54.5 cm (50th percentile), his height was 145 cm and weight was 36 kg, both –0.5 
SD. He had mildly dysmorphic features, with retrognathia and incomplete folding of the helix of both 
ears. The rest of the physical examination was normal, a was the neurological examination. 
The patient fulfilled ADI-R criteria for autism21 and scored 46 on the Childhood Autism Rating 
Scale25, indicating severe autism. His developmental age, evaluated with the Psycho-Educational 
Profile-Revised, was between 2 and 3.5 years. In the Vineland Adaptive Behavior Scales he achieved 
a level of 1.9 years for communication, 3.1 years for daily skills, and 2.7 years for socialization. 
Psychomotor evaluation showed that he walked awkwardly and had delayed motor acquisitions; he 
went down stairs one step at a time and was unable to hop on one foot. He was impulsive when 
performing tasks requiring fine motor coordination (such as cutting-out figures), but performed better 
when prompted. He could place four pieces in a puzzle, and was able to copy horizontal, vertical and 
diagonal lines as well as a circle, but failed to reproduce a cross and an X. Language evaluation by a 
speech pathologist showed that he was capable of non-verbal communication, but visual contact was 
rare and inappropriate. He understood simple commands and answered simple questions using images 
or gestures. Assessment with the Reynell Developmental Language Scales gave a score of 29 for 
verbal comprehension, equivalent to a developmental age of 2.6 years. He failed when spatial figures 
or colours were involved, or when two instructions were combined. Lexical comprehension was better, 
indicating a level equivalent to 4-5 years. He partly understood sorting instructions, obtaining an age 
equivalence of 4 years. Expression was reduced to single words, with numerous phonetic alterations 
that made his speech unintelligible out of context. Pronunciation of words was incomplete, and 
repetition did little to improve the initial utterance. He persevered and asked stereotyped questions. He 
used several idiosyncratic words, but in general language was used in an appropriate way, facilitating 
understanding by others. The results on the expressive language scale showed an age equivalence <18 
months. 
An EEG recording was inconclusive; there were unstructured rhythms but no synchronic activity. 
A brain MRI showed mild dilatation of the left temporal horn and a small arachnoid cyst in the 
temporal fossa (Fig 3). He was treated with fluoxetine and thioridazine. 
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DISCUSSION 
We report a male patient with a de novo interstitial duplication of the WBCR of paternal origin. The 
patient had autistic disorder, severe speech impairment and mental retardation. In the first report of a 
WBCR duplication, the proband had developmental dysphasia, with a severe delay in the acquisition 
of expressive language, mild mental deficiency and attention deficit-hyperactivity disorder (ADHD).16 
However, the developmental delay and ADHD were common to other family members who did not 
carry the duplication. The three additional patients with 7q11.23 duplication all had moderate to severe 
language disability, mild to moderate developmental delay, mild to severe mental retardation, and mild 
dysmorphic features (Table 1).17-19 These observations, combined with our case report, suggest that the 
duplication of the WBCR accounts for a highly variable and complex clinical pictures, encompassing 
speech and language delay, autism spectrum disorders and variable degrees of mental retardation. The 
only exception is the father of one patient, who also carried the duplication but was reportedly normal, 
except for syndactyly of the hands and feet, also present in other members of his family without the 
duplication. 16 Since the duplication was shown to be absent from the paternal grand-parents, the 
duplication could be mosaic in the father, which would explain the absence of clinical signs. However, 
this hypothesis needs further investigations and we cannot completely exclude the possibility that 
some 7q11.23 duplications remain clinically unnoticeable.  
So far, language impairment appears to be the most constant features in patients with WBCR 
duplication, together with a mild developmental delay and mild dysmorphic facies. Speech disability 
in patients with WBCR duplication contrasts with the relatively spared verbal abilities observed in 
WBS patients with the reciprocal deletion (Table 1). These findings support the existence of one or 
several genes in 7q11.23 that are sensitive to alterations in dosage and involved in the development of 
human language. Genotype-phenotype correlations performed in WBS patients with atypical deletions 
and studies of animals models have suggested that the genes located in the telomeric part of the 
7q11.23 region (CYLN2 to GTF2I) are the main candidates sensitive to dosage (i.e. presence of a 
phenotype when hemizygous) and involved in visuo-spatial and behavioural defects as well as mental 
disabilities.26-34 However, over-expression of genes, such as LIMK1, which do not seem to play a main 
role in the phenotype resulting from the deletion could participate in the clinical features due to the 
duplication. Finally, genes located outside the WBCR but that lie near the breakpoints could also have 
their expression altered by the rearrangement and participate to the phenotype although they do not 
vary in copy number.35 The precise role of the genes comprised in the 7q11.23 region in language 
development needs further investigation. 
Interestingly, a second patient with 7q11.23 duplication also had impaired social skills, evocative 
of Asperger syndrome.18 This suggests that the autism in our patient is indeed part of the 7q11.23 
duplication phenotype. In WBS, the WBCR deletion is associated both with features opposite to 
autism such as hypersociability but also with features found in autistic patients (poor social 
relationships, abnormal use of non-verbal behaviours including eye-to-eye gaze, facial expression and 
gestures to regulate social interaction).5 In addition, autism sometimes co-exists with WBS.9-12 These 
observations strongly suggest that the WBCR region or nearby regions also contain one or several 
genes sensitive to dosage and associated with impairment in social interactions. However, we cannot 
completely exclude that the autistic features in our patient could be partly due to unknown additional 
genetic or non-genetic factor(s).  
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The clinical variability observed in the five patients with a WBCR duplication reported so far does 
not seem to result from a difference in the length of the duplicated region although the precise extent 
of the duplication has as only been reported for one case.16 However, the variability could result from 
differences in the precise breakpoints and their effect on genes located nearby, especially the members 
of the GTF2 family of transcription factors (or TFII-I family, including GTF2I, GTF2IRD1 and 
GTF2IRD2), which have already been proposed as candidate genes for autism in a patient with an 
atypical 7q11 deletion.36 GTF2I hemizygozity has also been proposed to be a major cause of mental 
retardation found in WBD patients.26,28,33,37,38 Alternatively, this phenotypic variability, comparable to 
that observed in many other disorders arising from chromosomal rearrangements, could result from the 
interaction with other genetic, environmental or stochastic factors. 
Two distinct mechanisms could be involved in rearrangements mediated by duplicons: unequal 
interchromatid exchange during crossing-over and intrachromatid recombination. The first mechanism 
should theoretically lead to an incidence of duplications equivalent to that of deletions, whereas 
intrachromosomal events should mostly lead to deletions. The majority of the interstitial deletions of 
the 7q11.23 region have been shown to result from interchromosomal rearrangements during 
meiosis.1,3,39,40 There are several non-exclusive explanations for the apparent excess of cases with 
deletions: excessive early lethality of the duplication, underascertainement resulting from the absence 
of a “typical” phenotype that would prompt specific FISH diagnosis, or simply reduced 
penetrance/expressivity of the duplication, making most of the carriers asymptomatic. The observation 
that the WBCR duplication arose de novo in 3 out of 4 patients in whom the origin of the 
rearrangement was investigated and the absence of WBCR duplication in 300 control individuals, 
however, argues in favour of a deleterious role of the WBCR duplication, making therefore the last 
hypothesis unlikely. Our study, performed in a cohort of patients with autism spectrum disorders, 
indicates that the WBCR duplication is a rare cause of autism. The incidence of WBCR duplication in 
populations with expressive language delay, mental retardation, or autism spectrum disorders remains 
to be systematically evaluated.  
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Table 1  Clinical features of patients with 7q11.23 duplication compared to patients with Williams-Beuren Syndrome (WBS) 
Patients with 7q11.23 duplication Patients with WBS 
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5  
Reference Somerville et al., 2005 Kriek et al., 2006 Kirchloff et al., 2006 Torniero et al., 2007 This study  
Language impairment Severe  Moderate  Severe  Severe  Severe  Relatively spared language 
Visuo-spatial skills Good NA NA Poor Poor Poor 
Mental retardation  Mild Mild Severe Moderate Severe  Varies from mild to severe 
Social skills and 
psychiatric features 
 
Good social skills  
Attention deficit-
hyperactivity disorder 
NA 
 
 
Poor social skills / 
Asperger syndrome 
suspected 
Good social skills 
 
 
Autism 
Hyperactivity, 
Aggressive behaviour 
Good social skills  
(hypersociability) 
Attention deficit disorder 
Developmental delay + + (Mild) + + + + 
Dysmorphic features 
 
 
 
 
 
 
Mild: Retrognathia; Short 
philtrum; Dolichocephaly; 
High & narrow forehead; 
High & broad nose; 
High-arched palate ; 
Dental malocclusion ; 
Facial asymmetry 
Mild: Mild aberrant skull 
shape 
Mild: Low & broad 
forehead; 
Narrow palperal fissures; 
Protruding right ear with 
dysplastic lobe 
Mild: Low-set ears with 
mild posterior rotation; 
Round face; Short philtrum; 
Thin lips;Asymmetric 
opening of the mouth; 
Stocky short neck 
Mild:Retrognathia; 
Incomplete folding of 
the helix of both ears 
Characteristic: “Elfin 
face”;Prominent lips, wide 
mouth, periorbital fullness,  
Short nose with bulbous 
nasal tip, Long philtrum  
Mild micrognathia  
Dental malformation 
Neurological 
examination 
Mild dysmetria and mild 
difficulty with tandem gait 
NA 
 
NA 
 
Mild dysmetria with tandem 
gait and unipedal stance 
Normal but walks 
awkwardly  
Usually normal 
 
Brain MRI 
 
NA 
 
NA 
 
NA 
 
Cortical dysplasia of the left 
temporal lobe 
Mild dilatation of the 
left temporal horn 
Parieto-occipital 
abnormalities 
Perinatal hypotonia + NA NA - + + 
Cardiac anomaly None None None None None Supravalvar aortic stenosis 
Other features 
 
 
 
 
 
 
 
 
 
Unspecified sleep disorder Diagnosed with a 
trigonocephalic 
synostosis of the metopic 
ridge in the perinatal 
period 
 Talipes equino-varus and 
hip dysplasia at birth; dorsal 
kyphosis, truncal obesity, 
macrocephaly, astigmatism, 
diffuse hirsutism, stocky 
fingers, club feet;Intractable 
partial seizures 
Abnormal EEG (sharp 
waves on the left temporal 
region) 
Hyperacusis  
Hyperphagia 
Paroxystic episodes 
Hyperacusis; 
Infantile hypercalcemia; 
Common feeding difficulty; 
Short stature 
Familial history 
 
 
Attention and academic 
difficulties in parents, 
ADHD in sister 
Syndactyly (hand & feet) 
in the father and several 
other family members 
NA 
 
 
Healthy parents 
 
 
Mother with possible 
obsessive-compulsive 
disorder 
 
Origin of the 7q11 
duplication 
 
De novo  
(Maternal origin) 
 
Inherited from the father 
(absent from paternal 
grand-parents) 
Absent from the mother, 
father unavailable 
 
De novo  
(Maternal origin) 
 
De novo  
(Paternal origin) 
 
Mostly de novo 
 
 
NA: not available.
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Figure 1 Molecular analysis of the proband. A) Schematic representation of the WBCR and location of the 
markers used in this study. Genes are shown above and markers are indicated below with arrows. Solid arrows 
indicate microsatellite markers and dotted arrows indicate the real-time PCR assays (Q-PCR-1 to 4). The 
markers used for quantitative microsatellite analysis are underlined. B) Pedigree and electropherograms for 
microsatellite markers D73315 and D7S809 showing three different alleles which are indicative of a 7q11 
duplication in the proband. C) Haplotype analysis of the family showing the paternal origin of the 7q11 
duplication. Five microsatellite markers inside the minimal critical region (D7S2479, D7S2476, D7S809, 
D7S613, D7S3315) and two microsatellite markers outside the region (D7S672, D7S645) were genotyped at 
the 7q11 locus for the three family members. D) Fine analysis of the duplication detected in the proband by 
MLPA (7q11.23/ELN), showing a duplication of the FKBP6, FZD9, TBL2, STX1A, ELN, LIMK1, RFC2 and 
CYLN2 genes. The relative ratios indicate the relative area of the peak in the patient compared to that of a 
control. E) Delineation of the duplication. Four real-time PCR assays were used to quantify the allele copy 
number at the boundaries of the 7q11 minimal region. 
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Figure 2  FISH analysis of the duplication, showing three specific 7q11-probe sites on interphase cells (A) and 
two hybridization spots on metaphase chromosomes (B). The normal signal is indicated by arrowheads and the 
duplication by arrows. Magnification x1000. 
 
 
 
Figure 3  Brain MRI of the patient with the WBCR duplication showing mild dilatation of the left temporal 
horn (A) and a small arachnoid cyst in the temporal fossa (B). 
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